HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A novel ENU-generated truncation mutation lacking the spectrin-binding and C-terminal regulatory domains of Ank1 models severe hemolytic hereditary spherocytosis.

AbstractOBJECTIVE:
Hereditary spherocytosis (HS) is a heterogeneous group of spontaneously arising and inherited red blood cell disorders ranging from very mild subclinical cases to severe and life-threatening cases, with symptoms linked directly to the severity of the mutation at the molecular level. We investigated a novel mouse model in which the heterozygotes present with the diagnostic hallmarks of mild HS and surviving homozygotes phenocopy severe hemolytic HS.
MATERIALS AND METHODS:
We used N-ethyl-N-nitrosourea mutagenesis to generate random point mutations in the mouse genome and a dominant screen to identify mouse models of human hematopoietic disease. Gene mapping of the HS strain revealed a unique in-frame nonsense mutation arising from a single base transversion in exon 27 of Ank1 (strain designation: Ank1(E924X)). Employing conventional hematopoietic, pathological, biochemical, and cell biology assays, we characterized heterozygous and homozygous Ank1(E924X) mice at the biochemical, cellular, and pathophysiological levels.
RESULTS:
Although Ank1(E924X/E924X) red blood cell ghosts lack abundant full-length ankyrin-1 isoforms, N-terminal epitope ankyrin-1 antibodies reveal a band consistent with the theoretical size of a truncated mutant ankyrin-1. Using domain-specific antibodies, we further show that this protein lacks both a spectrin-binding domain and a C-terminal regulatory domain. Finally, using antisera that detect C-terminal residues of the products of alternative Ank1 transcripts, we find unique immunoreactive bands not observed in red blood cell ghosts from wild-type or Ank1(E924X) heterozygous mice, including a band similar in size to full-length ankyrin-1.
CONCLUSIONS:
The Ank1(E924X) strain provides a novel tool to study Ank1 and model HS.
AuthorsMichael R Hughes, Nicole Anderson, Steven Maltby, Justin Wong, Zorana Berberovic, Connie S Birkenmeier, D James Haddon, Kamal Garcha, Ann Flenniken, Lucy R Osborne, S Lee Adamson, Janet Rossant, Luanne L Peters, Mark D Minden, Robert F Paulson, Chen Wang, Dwayne L Barber, Kelly M McNagny, William L Stanford
JournalExperimental hematology (Exp Hematol) Vol. 39 Issue 3 Pg. 305-20, 320.e1-2 (Mar 2011) ISSN: 1873-2399 [Electronic] Netherlands
PMID21193012 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2011 ISEH - Society for Hematology and Stem Cells. Published by Elsevier Inc. All rights reserved.
Chemical References
  • Alkylating Agents
  • Ank1 protein, mouse
  • Ankyrins
  • Codon, Nonsense
  • Ethylnitrosourea
Topics
  • Alkylating Agents (adverse effects, pharmacology)
  • Amino Acid Sequence
  • Animals
  • Ankyrins (genetics, metabolism)
  • Codon, Nonsense
  • Disease Models, Animal
  • Erythrocytes (metabolism)
  • Ethylnitrosourea (adverse effects, pharmacology)
  • Female
  • Humans
  • Male
  • Mice
  • Mice, Mutant Strains
  • Protein Binding
  • Sequence Deletion
  • Spherocytosis, Hereditary (chemically induced, genetics, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: